174 related articles for article (PubMed ID: 10583266)
1. Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia.
Molica S; Vitelli G; Levato D; Gandolfo GM; Liso V
Br J Haematol; 1999 Dec; 107(3):605-10. PubMed ID: 10583266
[TBL] [Abstract][Full Text] [Related]
2. Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia.
Molica S; Vitelli G; Levato D; Ricciotti A; Digiesi G
Br J Cancer; 2002 Jan; 86(1):31-5. PubMed ID: 11857008
[TBL] [Abstract][Full Text] [Related]
3. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: correlation with the extent of angiogenesis and disease-progression risk in early disease.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Leuk Lymphoma; 2006 Jun; 47(6):1034-40. PubMed ID: 16840194
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia.
Bairey O; Zimra Y; Shaklai M; Rabizadeh E
Br J Haematol; 2001 May; 113(2):400-6. PubMed ID: 11380405
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia.
Molica S; Vacca A; Ribatti D; Cuneo A; Cavazzini F; Levato D; Vitelli G; Tucci L; Roccaro AM; Dammacco F
Blood; 2002 Nov; 100(9):3344-51. PubMed ID: 12384436
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia.
Aguayo A; O'Brien S; Keating M; Manshouri T; Gidel C; Barlogie B; Beran M; Koller C; Kantarjian H; Albitar M
Blood; 2000 Jul; 96(2):768-70. PubMed ID: 10887147
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression.
Molica S; Vitelli G; Levato D; Giannarelli D; Gandolfo GM
Cancer; 2001 Aug; 92(4):713-9. PubMed ID: 11550139
[TBL] [Abstract][Full Text] [Related]
9. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
[TBL] [Abstract][Full Text] [Related]
10. Increased serum levels of matrix metalloproteinase-9 predict clinical outcome of patients with early B-cell chronic lymphocytic leukaemia.
Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Cavazzini F; Squillace R; Mirabelli R; Digiesi G
Eur J Haematol; 2003 Jun; 70(6):373-8. PubMed ID: 12756019
[TBL] [Abstract][Full Text] [Related]
11. Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia.
Gora-Tybor J; Blonski JZ; Robak T
Eur Cytokine Netw; 2005; 16(1):41-6. PubMed ID: 15809205
[TBL] [Abstract][Full Text] [Related]
12. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
[TBL] [Abstract][Full Text] [Related]
13. Increased serum levels of vascular endothelial growth factor correlate with splenomegaly in polycythemia vera.
Murphy P; Ahmed N; Hassan HT
Leuk Res; 2002 Nov; 26(11):1007-1010. PubMed ID: 12363469
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.
Bachelot T; Ray-Coquard I; Menetrier-Caux C; Rastkha M; Duc A; Blay JY
Br J Cancer; 2003 Jun; 88(11):1721-6. PubMed ID: 12771987
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
16. Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival.
Bachtiary B; Selzer E; Knocke TH; Pötter R; Obermair A
Cancer Lett; 2002 May; 179(2):197-203. PubMed ID: 11888674
[TBL] [Abstract][Full Text] [Related]
17. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.
Gentile M; Cutrona G; Fabris S; Pesce EA; Baldini L; Di Raimondo F; Musolino C; Di Tonno P; Di Renzo N; Molica S; Brugiatelli M; Ilariucci F; Zupo S; Matis S; Maura F; Vigna E; Angrilli F; Recchia AG; Quarta G; Iannitto E; Fragasso A; Musto P; Spriano M; Vincelli I; Vallisa D; Cortelezzi A; Mauro FR; Foà R; Federico M; Neri A; Ferrarini M; Morabito F
Am J Hematol; 2013 Jul; 88(7):539-44. PubMed ID: 23553682
[TBL] [Abstract][Full Text] [Related]
18. Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia.
Molica S; Vitelli G; Levato D; Levato L; Dattilo A; Gandolfo GM
Haematologica; 1999 Mar; 84(3):208-11. PubMed ID: 10189383
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of preoperative serum vascular endothelial growth factor levels in patients with colorectal cancer and the effect of tumor surgery.
Karayiannakis AJ; Syrigos KN; Zbar A; Baibas N; Polychronidis A; Simopoulos C; Karatzas G
Surgery; 2002 May; 131(5):548-55. PubMed ID: 12019409
[TBL] [Abstract][Full Text] [Related]
20. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.
Tuttle RM; Fleisher M; Francis GL; Robbins RJ
J Clin Endocrinol Metab; 2002 Apr; 87(4):1737-42. PubMed ID: 11932308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
